The expression of PD-1 on lymphocytes has been widely discussed during recent years, and Waki et al. have reported that PD-1 expression on CD4+ and CD8+ T lymphocytes was correlated with OS among patients with lung cancer who received personalized peptide vaccination [22]. The gene discussed is CD8A; the disease is lung carcinoma.